Published in Microvasc Res on April 14, 2007
Stepping out of the flow: capillary extravasation in cancer metastasis. Clin Exp Metastasis (2007) 1.68
Molecular mechanisms involved in vascular interactions of the Lyme disease pathogen in a living host. PLoS Pathog (2008) 1.34
Impact of combined HDAC and mTOR inhibition on adhesion, migration and invasion of prostate cancer cells. Clin Exp Metastasis (2011) 1.00
Inhibiting galectin-1 reduces murine lung metastasis with increased CD4(+) and CD8 (+) T cells and reduced cancer cell adherence. Clin Exp Metastasis (2012) 0.91
Global gene expression analysis of the interaction between cancer cells and osteoblasts to predict bone metastasis in breast cancer. PLoS One (2012) 0.89
P-selectin-mediated platelet activation promotes adhesion of non-small cell lung carcinoma cells on vascular endothelial cells under flow. Mol Med Rep (2012) 0.88
Anti-angiogenesis therapy and gap junction inhibition reduce MDA-MB-231 breast cancer cell invasion and metastasis in vitro and in vivo. Sci Rep (2015) 0.75
p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci U S A (2009) 5.05
Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression. Nat Med (2006) 2.57
Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone. J Exp Med (2011) 2.38
The Drg-1 gene suppresses tumor metastasis in prostate cancer. Cancer Res (2003) 2.01
miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4. Cancer Res (2013) 1.94
Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1. Cancer Res (2008) 1.92
Metabolic genes in cancer: their roles in tumor progression and clinical implications. Biochim Biophys Acta (2010) 1.88
Cancer associated fibroblasts (CAFs) in tumor microenvironment. Front Biosci (Landmark Ed) (2010) 1.87
The human long non-coding RNA-RoR is a p53 repressor in response to DNA damage. Cell Res (2012) 1.66
Anti-cancer drugs targeting fatty acid synthase (FAS). Recent Pat Anticancer Drug Discov (2012) 1.46
Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression. Oncogene (2004) 1.42
Drug development against metastasis-related genes and their pathways: a rationale for cancer therapy. Biochim Biophys Acta (2008) 1.36
Mechanism of apoptosis induced by the inhibition of fatty acid synthase in breast cancer cells. Cancer Res (2006) 1.35
The tumor metastasis suppressor gene Drg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer. Cancer Res (2006) 1.35
Roles of AKT signal in breast cancer. Front Biosci (2007) 1.33
FAS expression inversely correlates with PTEN level in prostate cancer and a PI 3-kinase inhibitor synergizes with FAS siRNA to induce apoptosis. Oncogene (2005) 1.29
RhoC promotes metastasis via activation of the Pyk2 pathway in prostate cancer. Cancer Res (2008) 1.27
N-myc downstream regulated gene 1 modulates Wnt-β-catenin signalling and pleiotropically suppresses metastasis. EMBO Mol Med (2012) 1.24
Notch signaling: targeting cancer stem cells and epithelial-to-mesenchymal transition. Onco Targets Ther (2013) 1.23
WNT7A regulates tumor growth and progression in ovarian cancer through the WNT/β-catenin pathway. Mol Cancer Res (2012) 1.21
Hyaluronan synthase HAS2 promotes tumor progression in bone by stimulating the interaction of breast cancer stem-like cells with macrophages and stromal cells. Cancer Res (2011) 1.20
Aldo-keto reductase family 1 member B10 promotes cell survival by regulating lipid synthesis and eliminating carbonyls. J Biol Chem (2009) 1.19
PTEN up-regulates the tumor metastasis suppressor gene Drg-1 in prostate and breast cancer. Cancer Res (2004) 1.16
Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer. Mol Cancer (2014) 1.15
Acetyl-CoA carboxylase-a as a novel target for cancer therapy. Front Biosci (Schol Ed) (2010) 1.12
Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase. Breast Cancer Res Treat (2010) 1.11
Reactive astrocytes promote the metastatic growth of breast cancer stem-like cells by activating Notch signalling in brain. EMBO Mol Med (2013) 1.10
Wnt pathway and breast cancer. Front Biosci (2007) 1.08
Adenosine A(3) receptor suppresses prostate cancer metastasis by inhibiting NADPH oxidase activity. Neoplasia (2009) 1.07
KAI1 gene is engaged in NDRG1 gene-mediated metastasis suppression through the ATF3-NFkappaB complex in human prostate cancer. J Biol Chem (2011) 1.07
Role of myoepithelial cells in breast tumor progression. Front Biosci (Landmark Ed) (2010) 1.03
The role of tumor-associated macrophage in tumor progression. Front Biosci (Schol Ed) (2012) 0.99
Vitamin E succinate suppresses prostate tumor growth by inducing apoptosis. Int J Cancer (2006) 0.93
Targeting protein homodimerization: a novel drug discovery system. FEBS Lett (2005) 0.93
Interaction of Duffy antigen receptor for chemokines and KAI1: a critical step in metastasis suppression. Cancer Res (2007) 0.86
IL-2-inducible T-cell kinase modulates TH2-mediated allergic airway inflammation by suppressing IFN-γ in naive CD4+ T cells. J Allergy Clin Immunol (2013) 0.86
c-Maf increases apoptosis in peripheral CD8 cells by transactivating Caspase 6. Immunology (2009) 0.85
The role of tumor metastasis suppressors in cancers of breast and prostate. Front Biosci (2006) 0.83
Evaluation of the stability, bioavailability, and hypersensitivity of the omega-3 derived anti-leukemic prostaglandin: Δ(12)-prostaglandin J3. PLoS One (2013) 0.82
Inhibition of U6 snRNA Transcription by PTEN. Online J Biol Sci (2010) 0.82
Cacalol, a natural sesquiterpene, induces apoptosis in breast cancer cells by modulating Akt-SREBP-FAS signaling pathway. Breast Cancer Res Treat (2010) 0.78
Emerging Indications for Fractionated Gamma Knife Radiosurgery. Neurosurgery (2016) 0.77
Critical role of ADAM15 in tumor progression: targeting multiple factors for metastasis promotion. Future Oncol (2008) 0.76
Antineoplastic activity of Solidago virgaurea on prostatic tumor cells in an SCID mouse model. Nutr Cancer (2002) 0.76
miRNAs as biomarkers for brain metastasis of breast cancer. Biomark Med (2013) 0.75